株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

十二指腸癌:世界の治験レビュー

Duodenal Cancer Global Clinical Trials Review, H1, 2019

発行 GlobalData 商品コード 297516
出版日 ページ情報 英文 61 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
十二指腸癌:世界の治験レビュー Duodenal Cancer Global Clinical Trials Review, H1, 2019
出版日: 2019年05月31日 ページ情報: 英文 61 Pages
概要

当レポートでは、世界における十二指腸癌治療薬の治験について調査し、地域別、相別、ステータス別治験動向、主な企業や研究所等の治験プロファイルをまとめ、概略以下の構成でお届けします。

目次

イントロダクション

  • 十二指腸癌
  • レポートガイダンス

臨床試験:地域別

  • 臨床試験:国別
    • 臨床試験に寄与している上位国 - アジア太平洋地域
    • 臨床試験に寄与している上位5ヵ国 - 欧州
    • 臨床試験に寄与している上位国 - 北米

臨床試験 G7諸国

臨床試験 G7諸国、相別

臨床試験 G7諸国、治験ステータス別

臨床試験 E7諸国

臨床試験 相別

  • 進行中の治験:相別

臨床試験:治験ステータス別

未完了の治験

期間ごとの被験者数

有力なスポンサー

  • 主な治験参加企業

有望な治療薬

  • 臨床試験プロファイル
  • 臨床試験概要:上位企業
    • Silence Therapeutics AG
    • Oncothyreon Inc.
    • F. Hoffmann-La Roche Ltd.
  • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
    • National Cancer Institute
    • 和歌山県立医科大学
    • 名古屋大学
    • Seoul National University Hospital
    • 東京大学
    • Thomas Jefferson University
    • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
    • Odense University Hospital
    • Weill Cornell Medical College
    • USC Norris Comprehensive Cancer Center

5件の主要臨床プロファイル

付録

  • 略語
  • 定義
  • 調査方法
  • 二次調査
  • GlobalData について
  • お問い合わせ
  • 免責事項
  • 情報ソース

図表

図表

List of Tables

  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Region, 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, North America, Top Countries, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2019*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2019*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, E7 Countries (%), 2019*
  • Duodenal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase, 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*

List of Figures

  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Region (%), 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, G7 Countries (%), 2019*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2019*
  • Duodenal Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019*
  • Proportion of Duodenal Cancer to Oncology Clinical Trials, E7 Countries (%), 2019*
  • Duodenal Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2019*
  • Duodenal Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Duodenal Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019*
  • Duodenal Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019*
  • GlobalData Methodology
目次
Product Code: GDHC5679CTIDB

GlobalData's clinical trial report, "Duodenal Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Duodenal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Duodenal Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • List of Tables
  • List of Figures
  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Duodenal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Duodenal Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Duodenal Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
  • Source
Back to Top